Goldstein Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$307K Buy
3,378
+901
+36% +$82.2K 0.03% 185
2026
Q1
$254K Buy
2,477
+416
+20% +$47K 0.03% 175
2025
Q4
$258K Buy
2,061
+63
+3% +$8.03K 0.03% 173
2025
Q3
$268K Sell
1,998
-66
-3% -$8.66K 0.03% 160
2025
Q2
$281K Buy
2,064
+120
+6% +$15.8K 0.04% 142
2025
Q1
$258K Sell
1,944
-448
-19% -$57K 0.04% 151
2024
Q4
$271K Buy
2,392
+142
+6% +$16.4K 0.04% 147
2024
Q3
$257K Buy
+2,250
New +$247K 0.04% 149

Other funds holding ABT

Goldstein Advisors's ABT Position: Q2 2026 in Review

Goldstein Advisors increased its Abbott (ABT) stake by 36% in Q2 2026, buying an estimated $82.2K and bringing the position to 3,378 shares worth $307K. The position accounts for 0.03% of the portfolio, ranked #185.

Goldstein Advisors first reported a position in ABT in Q3 2024 and has held it in 8 quarters since. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Goldstein Advisors held 3,378 shares of Abbott worth $307K as of Q2 2026.
  • Goldstein Advisors bought 901 Abbott shares in Q2 2026, an estimated $82.2K.
  • Abbott made up 0.03% of Goldstein Advisors's portfolio in Q2 2026, its #185 holding.
  • Goldstein Advisors first reported a position in Abbott in Q3 2024 and has held it in 8 quarters since.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Goldstein Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.